| Dr Kayla Jo Hughes, PHARMD, BCPS | |
|
2301 8th Ave Ne Ste 225, Aberdeen, SD 57401 | |
| (605) 229-3500 | |
| (605) 229-3505 |
| Full Name | Dr Kayla Jo Hughes |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 2301 8th Ave Ne Ste 225, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306256979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 6071 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kayla Jo Hughes, PHARMD, BCPS 2301 8th Ave Ne Ste 225, Aberdeen, SD 57401-3253 Ph: (605) 229-3500 | Dr Kayla Jo Hughes, PHARMD, BCPS 2301 8th Ave Ne Ste 225, Aberdeen, SD 57401 Ph: (605) 229-3500 |
News Archive
Transoma Medical, Inc., manufacturer of Sleuth AT™, the only wireless, automated implantable cardiac monitoring system with programmable and frequent electrocardiogram (ECG) sampling, announced today the first enrollment and implant in the COMPLIANCE trial, a long-term study to compare external event recorders with implantable monitors in patients who have been prescribed catheter ablation therapy for atrial fibrillation (AF) at risk of post-procedure AF recurrence.
Scientists at Karolinska Institutet in Sweden describe in a new study how so-called DNA origami can enhance the effect of certain cytostatics used in the treatment of cancer. With the aid of modern nanotechnology, scientists can target drugs direct to the tumour while leaving surrounding healthy tissue untouched.
Researchers report an advance in the development of a blood test that could help detect pathological Alzheimer's disease in people who are showing signs of dementia.
In a screen of more than 100,000 potential drugs, only one, harmine, drove human insulin-producing beta cells to multiply, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai, funded by JDRF and the National Institutes of Health, and published online today in Nature Medicine.
Gilead Sciences, Inc. today announced topline results from a Phase 3 clinical trial (Study GS-US-334-0118) in Japan evaluating the once-daily nucleotide analog polymerase inhibitor sofosbuvir in combination with ribavirin (RBV) for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection.
› Verified 9 days ago
Adam Jason Waage, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 S State St Ste 101, Aberdeen, SD 57401 Phone: 605-225-1945 Fax: 605-725-0037 | |
Ms. Mary E Curtis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1815 6th Ave Se, Aberdeen, SD 57401 Phone: 605-229-5500 Fax: 605-229-6641 | |
Kevin Lee Hed, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1409 6th Ave Se Ste 2, Aberdeen, SD 57401 Phone: 605-262-0283 Fax: 605-262-0214 | |
Brant Haase, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 406 N 2nd St, Aberdeen, SD 57401 Phone: 701-202-7625 | |
Kirsten Nash, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2905 3rd Ave Se, Aberdeen, SD 57401 Phone: 605-626-4780 | |
Quentin Clifford Bury, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1409 6th Ave Se Ste 2, Aberdeen, SD 57401 Phone: 605-262-0283 Fax: 605-262-0214 |